NeuroPace (NASDAQ: NPCE) investors back board slate and PwC at 2026 meeting
Rhea-AI Filing Summary
NeuroPace, Inc. reported the results of its 2026 Annual Meeting of Stockholders held by live webcast on June 5, 2026. Stockholders elected Class II directors Lisa Andrade and Scott Huennekens to serve until the 2029 annual meeting and until their successors are elected and qualified.
Andrade received 15,194,450 votes for and 6,024,133 withheld, with 8,048,133 broker non-votes. Huennekens received 20,973,382 votes for and 245,201 withheld, with the same 8,048,133 broker non-votes. Stockholders also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 28,850,105 votes for, 209,301 against, and 207,310 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Lisa Andrade: 15,194,450 votes
Votes for Scott Huennekens: 20,973,382 votes
Votes for auditor ratification: 28,850,105 votes for
+2 more
5 metrics
Votes for Lisa Andrade
15,194,450 votes
Election as Class II director at 2026 annual meeting
Votes for Scott Huennekens
20,973,382 votes
Election as Class II director at 2026 annual meeting
Votes for auditor ratification
28,850,105 votes for
Ratification of PwC for fiscal year ending December 31, 2026
Votes against auditor ratification
209,301 votes against
Ratification of PwC for fiscal year ending December 31, 2026
Abstentions on auditor ratification
207,310 abstain
Ratification of PwC for fiscal year ending December 31, 2026
Key Terms
broker non-votes, independent registered public accounting firm, Annual Meeting of Stockholders, emerging growth company
4 terms
broker non-votes financial
"The results of the vote were ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of PricewaterhouseCoopers LLP as NeuroPace’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Annual Meeting of Stockholders financial
"held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) virtually via live webcast"
emerging growth company regulatory
"Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did NeuroPace (NPCE) stockholders decide at the 2026 annual meeting?
Stockholders elected two Class II directors and ratified PricewaterhouseCoopers LLP as auditor for 2026. Lisa Andrade and Scott Huennekens were elected, and PwC’s appointment received strong support based on the disclosed vote totals.
Were NeuroPace (NPCE) director nominees approved at the 2026 meeting?
Yes. Class II director nominees Lisa Andrade and Scott Huennekens were elected to serve until the 2029 annual meeting. Each nominee received more votes “for” than “withhold,” with additional broker non-votes reported in the results table.
Who will serve as NeuroPace (NPCE) Class II directors after the 2026 annual meeting?
Lisa Andrade and Scott Huennekens will serve as Class II directors following the 2026 meeting. They are expected to hold office until the 2029 annual meeting and until their successors are duly elected and qualified or earlier departure events occur.
When and how was NeuroPace’s 2026 annual stockholder meeting held?
The 2026 annual stockholder meeting was held on June 5, 2026, via live virtual webcast. The company reported that stockholders considered proposals described in its April 21, 2026 definitive proxy statement and disclosed final voting results for each item.